CTMX CYTOMX THERAPEUTICS INC
2026Q1 · CUSIP 23284F105 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
178
Δ holders QoQ
+57
Breadth percentile
Top 4%
Whale holders
82
Δ whales
+26
Inst. holding value
$908M
New positions
78
Closed positions
21
Price momentum (1Q)
-33.6%
Put / Call
4/8
Breadth history (34 quarters)
Past Lit Events & Aftermath 5 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 4% | — | — |
| 2025Q3 | Top 16% | +54.1% | +4.8% |
| 2025Q2 | Top 19% | +83.0% | +155.2% |
| 2024Q1 | Top 15% | — | — |
| 2018Q1 | Top 8% | -3.0% | -41.5% |
Options Sentiment
Put holders
4
QoQ: +2
Call holders
8
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.52
EPS YoY
-208.3%
Revenue (TTM)
$0.0B
Revenue YoY
-75.9%
Net margin
-166.4%
ROE
-18.5%
Debt ratio
11.0%
FCF (TTM)
-$80M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.